XB-010 is under clinical development by Exelixis and currently in Phase I for Triple-Negative Breast Cancer (TNBC).

CLN-619 is under clinical development by Cullinan Therapeutics and currently in Phase I for Refractory Multiple Myeloma.

January is National Radon Action Month, and University of Nevada, Reno Extension’s Nevada Radon Education Program is once ...

The Jackson County Health Department encourages residents to test their homes and buildings for radon gas this January. Radon ...

Lung cancer is the most common cause of cancer death in Ireland and two unusual signs on your hands could help detect the ...

The early detection of cancer in patients in Sussex has risen to its highest ever level, according to new NHS analysis. Of ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient ...

Rose Schwartz, left, whose husband Buddy died of cancer while under hospice care from Medi Home Hospice, is thankful for the ...

Lampang Cancer Hospital in northern Thailand has held an activity to educate people on the danger of PM2.5 fine dust and encourage them to use certain herbs to reduce the chance of getting lung cancer ...

Researchers have discovered why the lungs are often targeted by metastasizing cancer cells, pinpointing the amino acid ...

After the Surgeon General's warning, epidemiologist Dr. I-Min Lee discusses the science about the link between alcohol consumption and cancer.

A lucky buyer will have the opportunity to step inside the world of Walter White. The fictional character's real-life home is ...